AUTOBIO Overview
Company Headquarters: China
Founded: 1998
Workforce: ~ 5000
Company Working:
Autobio is specialized in the field of clinical, immunological diagnosis. It is one of the leading manufacturers of in-vitro diagnostic reagents and instruments. It operates through different segments such as immunology, microbiology, and biochemistry. It is also actively deployed in the field of molecular detection. Autobio has been listed on the Shanghai Stock Exchange on September 1, 2016. It is the first in-vitro diagnostic manufacturing company listed on the Shanghai Stock Exchange in China. It has established the National Certified Enterprise Technology Center, the National and Local Joint Engineering Laboratory for Immunoassay Automation, and the Henan Province Immunodiagnostic Reagent Engineering Technology Research Center in China.
Strategy
The strategy of Autobio is to provide medical laboratories with products and services with better price ratios and better quality. It focuses on the development and manufacturing of in-vitro diagnostic reagents and instruments. It also focuses on the quality of manufacturing instruments and global resource integration.
